Nicotine modulates gelatinase B (MMP-9) and epilysin (MMP-28) expression in reconstituted human oral epithelium

J Oral Pathol Med. 2011 Jan;40(1):33-6. doi: 10.1111/j.1600-0714.2010.00949.x. Epub 2010 Oct 4.

Abstract

Oral epithelial keratinocytes express nicotinic cholinergic receptors which activation modulates keratinocytes differentiation and migration through different metabolic pathways. Matrix metalloproteinases (MMPs) are Zn-dependent enzyme involved in cell migration. Among them, gelatinase B (MMP-9) and epilysin (MMP-28) are two MMPs expressed by human keratinocytes during both wound healing and proliferation. Their expression has been investigated in a reconstituted human oral epithelium (HOE) exposed to nicotine (Nic, 1-50 μM) for 72 h both in the absence and presence of the nicotinic antagonist mecamylamine (Mec), H7, a PKC inhibitor and PD98059, a MAPK inhibitor (PD). At the end of treatment, MMP-28 expression has been analyzed in epithelium sections using an anti-MMP-28 antibody, whereas MMP-9 presence and activity has been measured in cell-conditioned medium analyzed by gelatine zymography. The expression of MMP-9 was reduced by Nic in a dose-dependent fashion and this effect was antagonized by Mec, H7 and PD. On the other hand, Nic increased the expression of MMP-28, and this effect was blocked both by H7 and PD, whereas Mec even enforced it. Nic effects on MMP-9 and MMP-28 expression by oral keratinocytes were not previously reported and these data suggest MMPs expression mediated by PKC and MAPK as a possible target for Nic toxicity in oral epithelium.

MeSH terms

  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Epithelium / drug effects
  • Epithelium / enzymology
  • Extracellular Signal-Regulated MAP Kinases / antagonists & inhibitors
  • Flavonoids / pharmacology
  • Gene Expression Regulation / drug effects
  • Humans
  • Keratinocytes / drug effects*
  • Keratinocytes / enzymology
  • Matrix Metalloproteinase 9 / drug effects*
  • Matrix Metalloproteinase 9 / metabolism
  • Matrix Metalloproteinases, Secreted / drug effects*
  • Matrix Metalloproteinases, Secreted / metabolism
  • Mecamylamine / pharmacology
  • Mouth Mucosa / cytology
  • Mouth Mucosa / drug effects
  • Mouth Mucosa / enzymology
  • Nicotine / pharmacology*
  • Nicotinic Agonists / pharmacology*
  • Nicotinic Antagonists / pharmacology
  • Protein Kinase C / antagonists & inhibitors
  • Smoking / adverse effects
  • Wound Healing / drug effects

Substances

  • Enzyme Inhibitors
  • Flavonoids
  • Nicotinic Agonists
  • Nicotinic Antagonists
  • Mecamylamine
  • Nicotine
  • Protein Kinase C
  • Extracellular Signal-Regulated MAP Kinases
  • MMP28 protein, human
  • Matrix Metalloproteinases, Secreted
  • Matrix Metalloproteinase 9
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one